BPC-157 + TB-500 + KPV
Also known as: Triple healing blend, BPC-157/TB-500/KPV
Three-way pre-mixed blend combining two tissue-repair peptides with an anti-inflammatory tripeptide. BPC-157 is a synthetic pentadecapeptide studied in animals for tendon, ligament, and GI healing via angiogenesis (VEGFR2). TB-500 is a synthetic fragment of Thymosin beta-4 that promotes actin regulation, cell migration, and angiogenesis in tissue-repair models. KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH and acts as an NF-kB-inhibiting anti-inflammatory. None of the three components is FDA-approved for human therapeutic use, and there are no controlled human efficacy or safety trials for this specific three-component combination; the rationale is inferred from individual grey-market research peptides.
Who's worth your money for BPC-157 + TB-500 + KPV
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
No sellers for BPC-157 + TB-500 + KPV are indexed yet — we add vendors and their prices as we find them.
Watch BPC-157 + TB-500 + KPV
Get one email when the market actually moves — no newsletter, no noise.
About BPC-157 + TB-500 + KPV
CAS
—
Molecular formula
—
Typical dose range
Vendor-dependent; component norms: BPC-157 250-500 mcg/day subcutaneous; TB-500 2-5 mg/week subcutaneous; KPV 200-500 mcg/day. No validated combination dosing exists.
Half-life
BPC-157: disputed (under 30 minutes per most data); TB-500: ~2 hours plasma; KPV: short and not well characterized in humans
Common research uses
Safety notes
Not FDA-approved for human therapeutic use; sold as a research-only / grey-market blend. No combination-specific human safety data; risks are extrapolated from limited research on the individual components. Not evaluated by WADA as a blend.
Reconstitution
Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution.
COAs for BPC-157 + TB-500 + KPV
4 third-party tests across 3 vendors. Each card links to the full report.
For
Wolverine+ (KPV/BPC-157/Thymosin Beta-4)
by Peptide Plugs· batch GGB-03-BK
For
BPC-157/TB-4/KPV
by Ion Peptide· batch BKP
For
KPV/BPC-157/Thymosin Beta-4
by Orbitrex Peptides· batch ZAOB01
For
KPV/BPC-157/Thymosin Beta-4
by Orbitrex Peptides· batch ZAOB02
Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.